Moderna, Inc.
NASDAQ: MRNA
$129.65
-$0.07 (-0.1%)
Closing price January 15, 2021
The November 30 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
1 month ago
Wednesday's top analyst calls included American Express, Apple, Baidu, CarMax, Chewy, Lululemon Athletica, Micron Technology, Moderna, Slack, Walt Disney and Zoom Video Communications.
1 month ago
Last Updated: 1 month ago
COVID-19 stocks were on the move on Wednesday after a few huge updates in regards to vaccine approval.
1 month ago
Moderna shares continued to run higher on Monday after the company announced an update for the primary efficacy analysis for its late-stage coronavirus vaccine trial.
1 month ago
The November 13 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
1 month ago
Here is an update on the stocks of each major player in the COVID-19 arena, including brief trading histories and consensus price targets.
1 month ago
Monday's top analyst upgrades and downgrades included Darden Restaurants, Foot Locker, Gap, Kellogg, Moderna, Philip Morris International, Prologis, Rockwell Automation and Texas Roadhouse.
1 month ago
Last Updated: 1 month ago
Tuesday's top analyst upgrades and downgrades included AECOM, BBVA, Cheniere Energy, Chevron, DraftKings, General Motors, Moderna, Novavax, Palo Alto Networks and Penn National Gaming.
2 months ago
Last Updated: 2 months ago
Moderna reported a 95.4% effectiveness rate for its COVID-19 vaccine. This is the second vaccine to hit more than 90% efficacy in the past week.
2 months ago
Wednesday's top analyst upgrades and downgrades included AIG, CrowdStrike, Datadog, Devon Energy, eGain, Lyft, Moderna, Occidental Petroleum, Peloton Interactive and Yelp.
2 months ago
Last Updated: 2 months ago
When Moderna reported its most recent quarterly results before the markets opened on Thursday, the earnings (or loss in this case) were not the most important feature of the report.
2 months ago
The October 15 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
2 months ago
The September 30 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
3 months ago
Many health care products become much more popular because of endorsements and advertising efforts. It is a longstanding practice that has come under fire by both political parties in the United...
3 months ago
Last Updated: 3 months ago
President Trump and the First Lady have tested positive for COVID-19. That begs the question, now more than ever, of where we stand with a coronavirus vaccine.
3 months ago